Cyprotex Discovery Limited Overview
Company Headquarters: England, UK
Founded: 1999
Workforce: ~120
Company Working: Cyprotex Discovery Limited specializes in ADME-Tox in vitro and in silico services. In vitro ADME screening to support discovery projects, regulatory in vitro ADME and DDI studies during preclinical and clinical development, specialist mechanistic in vitro human and animal toxicity models (e.g. 3D models and MEA electrophysiology), and PBPK/QSAR modeling expertise are all part of this. In addition to directly assisting clients, the company places a strong emphasis on R&D, with its scientists regularly presenting their findings at scientific conferences and through publications. Cyprotex, an Evotec company, and has facilities in Alderley Park near Macclesfield, UK, and Framingham, Massachusetts, USA. The company employs dedicated and highly qualified individuals who have demonstrated experience in a wide range of specialist techniques acquired across various industries. The majority of its clients are involved in pharmaceutical research, but it also works with clients in the chemical, cosmetics and personal care, agrichemical, and tobacco industries.
Strategy
Cyprote prioritizes employee training and education. It strives to provide fair, respectful, and appealing working conditions that foster growth for and with its employees. Furthermore, the working environment it provides for its employees must be safe and health-promoting. Furthermore, it seeks long-term, strong partnerships as well as co-owned pipeline programs.
